SERA PROGNOSTICS, INC. Finance Lease, Right-of-Use Asset, Amortization
SERA PROGNOSTICS, INC. (SERA) reported Finance Lease, Right-of-Use Asset, Amortization of $77.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:FinanceLeaseRightOfUseAssetAmortization · last filed 2026-08-12
- SERA PROGNOSTICS, INC. finance lease, right-of-use asset, amortization for the quarter ending 2026-06-30 was $77.00K, a 1.28% decline year-over-year.
- SERA PROGNOSTICS, INC. finance lease, right-of-use asset, amortization for the quarter ending 2026-03-31 was $78.00K, a 0.00% change year-over-year.
- SERA PROGNOSTICS, INC. finance lease, right-of-use asset, amortization for the quarter ending 2025-12-31 was $79.00K, a 0.00% change year-over-year.
- SERA PROGNOSTICS, INC. finance lease, right-of-use asset, amortization for the quarter ending 2025-09-30 was $78.00K, a 0.00% change year-over-year.
- SERA PROGNOSTICS, INC. finance lease, right-of-use asset, amortization for fiscal 2025 was $314.00K, a 0.00% change from fiscal 2024.
- SERA PROGNOSTICS, INC. finance lease, right-of-use asset, amortization for fiscal 2024 was $314.00K, a 0.64% increase from fiscal 2023.
- SERA PROGNOSTICS, INC. finance lease, right-of-use asset, amortization for fiscal 2023 was $312.00K, a 11.43% increase from fiscal 2022.
- SERA PROGNOSTICS, INC. finance lease, right-of-use asset, amortization for fiscal 2022 was $280.00K.
| Period end | Finance Lease, Right-of-Use Asset, Amortization 3 month | Finance Lease, Right-of-Use Asset, Amortization 6 month | Finance Lease, Right-of-Use Asset, Amortization 9 month | Finance Lease, Right-of-Use Asset, Amortization 12 month |
|---|---|---|---|---|
| 2026-06-30 | $77.00K 10-Q · filed 2026-08-12 | $155.00K 10-Q · filed 2026-08-12 | $234.00K derived: sum of 3 quarters · filed 2026-08-12 | $312.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2026-03-31 | $78.00K 10-Q · filed 2026-05-06 | $157.00K derived: sum of 2 quarters · filed 2026-05-06 | $235.00K derived: sum of 3 quarters · filed 2026-05-06 | $313.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-12-31 | $79.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | $157.00K derived: sum of 2 quarters · filed 2026-03-18 | $235.00K derived: sum of 3 quarters · filed 2026-08-12 | $314.00K 10-K · filed 2026-03-18 |
| 2025-09-30 | $78.00K 10-Q · filed 2025-11-13 | $156.00K derived: sum of 2 quarters · filed 2026-08-12 | $235.00K 10-Q · filed 2025-11-13 | $313.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-06-30 | $78.00K 10-Q · filed 2026-08-12 | $157.00K 10-Q · filed 2026-08-12 | $235.00K derived: sum of 3 quarters · filed 2026-08-12 | $313.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-03-31 | $78.00K 10-Q · filed 2026-05-06 | $157.00K derived: sum of 2 quarters · filed 2026-05-06 | $235.00K derived: sum of 3 quarters · filed 2026-05-06 | $313.00K derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $79.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | $157.00K derived: sum of 2 quarters · filed 2026-03-18 | $235.00K derived: sum of 3 quarters · filed 2026-03-18 | $314.00K 10-K · filed 2026-03-18 |
| 2024-09-30 | $78.00K 10-Q · filed 2025-11-13 | $156.00K derived: sum of 2 quarters · filed 2025-11-13 | $235.00K 10-Q · filed 2025-11-13 | $302.00K derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | $78.00K 10-Q · filed 2025-08-06 | $157.00K 10-Q · filed 2025-08-06 | $224.00K derived: sum of 3 quarters · filed 2025-08-06 | $302.00K derived: sum of 4 quarters · filed 2025-08-06 |
| 2024-03-31 | $78.00K 10-Q · filed 2025-05-07 | $146.00K derived: sum of 2 quarters · filed 2025-05-07 | $224.00K derived: sum of 3 quarters · filed 2025-05-07 | $307.00K derived: sum of 4 quarters · filed 2025-05-07 |
| 2023-12-31 | $68.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-19 | $146.00K derived: sum of 2 quarters · filed 2025-03-19 | $229.00K derived: sum of 3 quarters · filed 2025-03-19 | $312.00K 10-K · filed 2025-03-19 |
| 2023-09-30 | $78.00K 10-Q · filed 2024-11-06 | $161.00K derived: sum of 2 quarters · filed 2024-11-06 | $244.00K 10-Q · filed 2024-11-06 | $328.00K derived: sum of 4 quarters · filed 2024-11-06 |
| 2023-06-30 | $83.00K 10-Q · filed 2024-08-07 | $166.00K 10-Q · filed 2024-08-07 | $250.00K derived: sum of 3 quarters · filed 2024-08-07 | $333.00K derived: sum of 4 quarters · filed 2024-08-07 |
| 2023-03-31 | $83.00K 10-Q · filed 2024-05-08 | $167.00K derived: sum of 2 quarters · filed 2024-05-08 | $250.00K derived: sum of 3 quarters · filed 2024-05-08 | $317.00K derived: sum of 4 quarters · filed 2024-05-08 |
| 2022-12-31 | $84.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-20 | $167.00K derived: sum of 2 quarters · filed 2024-03-20 | $234.00K derived: sum of 3 quarters · filed 2024-03-20 | $280.00K 10-K · filed 2024-03-20 |
| 2022-09-30 | $83.00K 10-Q · filed 2023-11-08 | $150.00K derived: sum of 2 quarters · filed 2023-11-08 | $196.00K 10-Q · filed 2023-11-08 | |
| 2022-06-30 | $67.00K 10-Q · filed 2023-08-09 | $113.00K 10-Q · filed 2023-08-09 | ||
| 2022-03-31 | $16.00K 10-Q · filed 2023-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |